SciELO - Scientific Electronic Library Online

 
vol.27 issue3A clinical epidemiologic study in a schistosomiasis mansoni endemic area (Tuparecê, Minas Gerais)Efficacy of albendazole in the treatment of enterobiasis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista do Instituto de Medicina Tropical de São Paulo

Print version ISSN 0036-4665

Abstract

CARVALHO, Silvino Alves de et al. Neurotoxicity of oxamniquine in the treatment of human infection due to S. mansoni. Rev. Inst. Med. trop. S. Paulo [online]. 1985, vol.27, n.3, pp. 132-142. ISSN 0036-4665.  http://dx.doi.org/10.1590/S0036-46651985000300004.

One hundred and eighty patients from the "Clínica de Doenças Infecciosas e Parasitárias do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo" with mansonic schistosomiasis have been treated with oxamniquine (single oral dose 12.5 — 15 mg or 16-20 mg/kg body weight, respectively to patients younger or older than 15 years old). The patients were 5 to 65 years old and the predominant clinical forms were intestinal and hepato-intestinal disease. The main neuropsychiatric side effects were: drowsiness (50.6%), dizziness (41.1%), headache (16.1%), temporary amnesia (2.2%), behaviour disturbances (1.7%), chills (1.1%), seizures (1.1%). In 20 patients the neurotoxicity associated with the drug has been evaluated comparing the electroencephalogram before and after the treatment. Alterations have been detected in 3 (15%) but were not associated with neuropsychiatric manifes- tations. The results show that oxamniquine determines toxic side effects in the neuropsychiatric area.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese